E
Elicera Therapeutics AB
STO:ELIC
Elicera Therapeutics AB
STO:ELIC
Price:
5.4
SEK
-2.53%
Market Cap:
kr262.1m
Income Statement
Earnings Waterfall
Elicera Therapeutics AB
Elicera Therapeutics AB
Income Statement
Elicera Therapeutics AB
Elicera Therapeutics AB
Currency: SEK
| Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Revenue |
4
N/A
|
12
+187%
|
11
-4%
|
13
+14%
|
12
-6%
|
4
-65%
|
7
+66%
|
4
-40%
|
6
+40%
|
14
+128%
|
11
-21%
|
|
| Operating Income | ||||||||||||
| Operating Expenses |
(22)
|
(28)
|
(28)
|
(33)
|
(34)
|
(23)
|
(24)
|
(24)
|
(23)
|
(27)
|
(29)
|
|
| Selling, General & Administrative |
(6)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(7)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Other Operating Expenses |
(16)
|
(22)
|
(23)
|
(28)
|
(29)
|
(18)
|
(19)
|
(18)
|
(17)
|
(21)
|
(22)
|
|
| Operating Income |
(18)
N/A
|
(16)
+11%
|
(17)
-8%
|
(20)
-19%
|
(22)
-7%
|
(19)
+11%
|
(17)
+12%
|
(20)
-16%
|
(17)
+15%
|
(14)
+17%
|
(18)
-31%
|
|
| Pre-Tax Income | ||||||||||||
| Interest Income Expense |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Pre-Tax Income |
(18)
N/A
|
(16)
+12%
|
(16)
-5%
|
(20)
-19%
|
(21)
-7%
|
(18)
+12%
|
(16)
+12%
|
(19)
-16%
|
(16)
+15%
|
(13)
+18%
|
(17)
-33%
|
|
| Net Income | ||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(18)
|
(16)
|
(16)
|
(20)
|
(21)
|
(18)
|
(16)
|
(19)
|
(16)
|
(13)
|
(17)
|
|
| Net Income (Common) |
(18)
N/A
|
(16)
+12%
|
(16)
-5%
|
(20)
-19%
|
(21)
-7%
|
(18)
+12%
|
(16)
+12%
|
(19)
-16%
|
(16)
+15%
|
(13)
+18%
|
(17)
-33%
|
|
| EPS (Diluted) |
-0.89
N/A
|
-0.79
+11%
|
-0.83
-5%
|
-0.93
-12%
|
-0.59
+37%
|
-0.52
+12%
|
-0.46
+12%
|
-0.53
-15%
|
-0.34
+36%
|
-0.42
-24%
|
-0.38
+10%
|
|
Switch to:
Switch to:
See Also
Discover More
